Authors
Monaghan, Phillip JLord, S
St John, A
Sandberg, S
Cobbaert, C
Lennartz, L
Verhagen-Kamerbeek, W
Ebert, C
Bossuyt, P
Horvath, A
Affiliation
Department of Clinical Biochemistry, The Christie Pathology PartnershipIssue Date
2016-09-01
Metadata
Show full item recordAbstract
The introduction of new biomarkers can lead to inappropriate utilization of tests if they do not fill in existing gaps in clinical care. We aimed to define a strategy and checklist for identifying unmet needs for biomarkers.Citation
Biomarker development targeting unmet clinical needs. 2016, 460:211-9 Clin. Chim. ActaJournal
Clinica Chimica ActaDOI
10.1016/j.cca.2016.06.037PubMed ID
27374304Type
ArticleLanguage
enISSN
1873-3492ae974a485f413a2113503eed53cd6c53
10.1016/j.cca.2016.06.037
Scopus Count
Collections
Related articles
- Practical guide for identifying unmet clinical needs for biomarkers.
- Authors: Monaghan PJ, Robinson S, Rajdl D, Bossuyt PMM, Sandberg S, St John A, O'Kane M, Lennartz L, Röddiger R, Lord SJ, Cobbaert CM, Horvath AR
- Issue date: 2018 Jul
- A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
- Authors: Foy JM, Earls MF
- Issue date: 2005 Jan
- [Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise].
- Authors: Morgano GP, Davoli M, Moja L, Amato L, Ferroni E, Tirani M
- Issue date: 2015 Jun
- Guidelines for the use of biomarkers: principles, processes and practical considerations.
- Authors: Horvath AR, Kis E, Dobos E
- Issue date: 2010
- Risk management frameworks for human health and environmental risks.
- Authors: Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S
- Issue date: 2003 Nov-Dec